(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

APEXBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

APEXBIO

ST13

US500000086102910

Class

5, 10

Filing

86102910

Registration

4559434

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

06/19/2024

Trademark type

Combined

Nice classes

5, 10

Filing date

10/28/2013

Registration date

07/01/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/19/2024

Last transaction

06/19/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/21/2003

First use in commerce

09/10/2004

Drawing code

5

Owner type

03

Owner location

Hsinchu City, TW

Examiner

BLOHM, LINDA

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "APEXBIO" in stylized bold font.

Holders and representatives

Holders

A. C. (pessoa física)

Representatives

Jeannine A Rittenhouse IPHORGAN LTD.

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

reagent strips for medical diagnostic use; glucose control solution for medical diagnostic use; uric acid control solution for medical diagnostic use; hemoglobin testing agents for medical diagnostic use; cholesterol testing agents for medical diagnostic use; lactic acid testing agents for medical diagnostic use

Class 10

testing and analytical apparatus for medical diagnostic use; blood uric monitoring apparatus for medical diagnostic use; blood glucose monitoring apparatus for medical use; lancets; hemoglobin testing apparatus for medical diagnostic use; cholesterol testing apparatus for medical diagnostic use; lactic acid testing apparatus for medical diagnostic use

Publications

History of USPTO decisions and trademark events.

27 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/19/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/19/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/19/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/19/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

03/18/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/01/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/03/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/03/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/03/2019

E815

TEAS SECTION 8 & 15 RECEIVED

07/23/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/01/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

07/01/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/15/2014

PUBO

PUBLISHED FOR OPPOSITION

04/15/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/03/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/26/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/07/2014

ALIE

ASSIGNED TO LIE

03/07/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/18/2014

XAEC

EXAMINER'S AMENDMENT ENTERED

02/17/2014

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/17/2014

GNEA

EXAMINERS AMENDMENT E-MAILED

02/17/2014

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/17/2014

DOCK

ASSIGNED TO EXAMINER

02/13/2014

MPMK

NOTICE OF PSEUDO MARK E-MAILED

11/05/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/02/2013

NWAP

NEW APPLICATION ENTERED

10/31/2013

Continuous trademark protection

Get notified about every new filing that threatens APEXBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.